Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women

Al Altomari, Chairman and CEO of Agile Therapeutics Inc AGRX, was recently interviewed by Benzinga.

Agile Therapeutics says it is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Its products and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.

The company’s flagship product is Twirla® (levonorgestrel and ethinyl estradiol), a non-daily prescription contraceptive utilizing a transdermal system. Twirla is based on proprietary transdermal patch technology, called Skinfusion®, designed to allow drug delivery through the skin. 

Watch the full interview here:


This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Featured photo by Brittani Burns on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechPenny StocksInterviewGeneralAgile Therapeutics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!